Singular Genomics Systems, Inc.·4

Dec 17, 5:34 PM ET

Meeter Dalen 4

4 · Singular Genomics Systems, Inc. · Filed Dec 17, 2024

Insider Transaction Report

Form 4
Period: 2024-12-15
Meeter Dalen
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-152091,874 total
    Common Stock (209 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-15+2099,002 total
Footnotes (4)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Includes 100 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
  • [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F4]The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4